Plotting a Path for Tissue Reconstruction

Tissium's co-founder and Chief Innovation Officer, Maria Pereira chronicles her journey into healthcare and how a plan to mend heart tissue led to the formation of a company.

Omar Ford

January 29, 2023

1 Min Read
Image courtesy of Tissium

Tissium was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. The company has made tremendous strides since it began. 

Currently, the Company has a pipeline of seven products across three verticals, including sutureless nerve repair, hernia repair and cardiovascular sealants. Each product is designed to enhance the tissue reconstruction process in a unique way. In addition, the company develops complementary delivery and activation devices for enhanced performance and usability of its products.

Tissium's co-founder and Chief Innovation Officer, Maria Pereira spoke to Let's Talk Medtech about the company's success and many of the hurdles and challenges it was facing.  You can listen to the conversation below. 



About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like